人睾丸特异性肌动蛋白加帽蛋白β3作为男性不育可能生物标志物的系统表征
该研究系统表征了人肌动蛋白加帽蛋白β3(hCPβ3)在睾丸中的表达、定位动态及其与男性不育的关联。研究发现hCPβ3在睾丸特异性表达,与hCPα3形成复合物,在精子发生各阶段定位动态变化,且在少精子症和/或弱精子症患者精子中异常染色比例显著高于正常精子症组,提示其可能与男性不育相关。
要点
- hCPβ3在睾丸中特异性表达,与hCPα3形成蛋白复合物并共定位。
- 少精子症和/或弱精子症组异常染色精子比例(52.4±3.0%)显著高于正常精子症组(31.2±2.5%)(P<0.001)。
- hCPβ3与hCPα3联合可能参与精子发生并与男性不育相关。
核心结论
- hCPβ3在睾丸中表达,在精子发生过程中定位动态变化,与男性不育有一定关联;hCPβ3与hCPα3联合可能在精子发生中起重要作用并与男性不育相关。
研究设计与样本
- 研究分析了证实有生育力男性的新鲜精液样本、梗阻性无精子症男性的冷冻保存睾丸组织,以及正常精子症志愿者(Normo组,n=20)和少精子症和/或弱精子症不育男性(O+A组,n=21)的冷冻保存精子。
- 采用RT-PCR和蛋白质印迹分析组织特异性表达,构建单质粒串联表达载体进行共免疫沉淀分析,并用免疫荧光和免疫组化分析蛋白表达及定位。
主要发现
- RT-PCR显示hcpβ3 mRNA仅在睾丸中表达,蛋白质印迹检出hCPβ3,共免疫沉淀显示hCPα3与hCPβ3形成蛋白复合物。
- 精子发生各阶段hCPβ3定位动态变化,从精原细胞胞质轻微信号,到精母细胞起明显表达,并从胞质迁移至顶体帽和顶体,成熟精子中聚集于顶体后区、中段较少。
- 双染分析显示hCPα3在各阶段与hCPβ3定位一致,Normo组多数精子被两者均匀染色,O+A组异常染色(异质性或缺乏染色)精子显著多于Normo组(P<0.001)。
- 异常染色百分比在O+A组为52.4±3.0%,高于Normo组的31.2±2.5%;仅限形态正常精子时,O+A组为39.9±2.9%,仍高于Normo组的22.5±2.1%(P<0.001)。
临床怎么用
- 作者认为hCPα3和hCPβ3表达改变可能不仅是男性不育的原因,也可能是辅助生殖技术(ART)结果的预后因素。
- 作者认为它们可能是有用的生物标志物,用于确定ART中人精子的受精能力。
局限性
- 由于难以收集人新鲜睾丸样本,研究使用了睾丸精子提取的冷冻保存样本。
- 为检查生精细胞相互作用或曲细精管内定位,健康男性新鲜睾丸样本是理想选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is actin capping protein (CP) β3 involved in human spermatogenesis and male infertility? SUMMARY ANSWER: Human CPβ3 (hCPβ3) is expressed in testis, changes its localization dynamically during spermatogenesis, and has some association with male infertility. WHAT IS KNOWN ALREADY: The testis-specific α subunit of CP (CPα3) was previously identified in human, and mutations in the cpα3 gene in mouse were shown to induce malformation of the sperm head and male infertility. However, CPβ3, which is considered to be a heterodimeric counterpart of CPα3, has been neither characterized in human nor reported in association with male infertility. STUDY DESIGN, SIZE, DURATION: To confirm the existence of CPβ3 in human testis, fresh semen samples from proven fertile men were analyzed. To investigate protein expression during spermatogenesis, cryopreserved testis obtained from men with obstructive azoospermia were examined by immunofluorescent analysis. To assess the association of CP with male infertility, we compared protein expression of human CPα3 (hCPα3) and hCPβ3 using immunofluorescent analysis of cryopreserved sperm between men with normozoospermia (volunteers: Normo group, n = 20) and infertile men with oligozoospermia and/or asthenozoospermia (O + A group, n = 21). PARTICIPANTS/MATERIALS, SETTING, METHODS: The tissue-specific expression of hCPβ3 was investigated by RT-PCR and Western blot analysis. To investigate whether hCPα3 and hCPβ3 form a heterodimer, a tandem expression vector containing hcpα3 tagged with monomeric red fluorescent protein 1 and hcpβ3 tagged with enhanced green fluorescent protein in a single plasmid was constructed and analyzed by co-immunoprecipitation (Co-IP) assay. The protein expression profiles of hCPα3 and hCPβ3 during spermatogenesis were examined by immunohistochemical analysis using human spermatogenic cells. The protein expressions of hCPα3 and hCPβ3 in sperm were compared between the Normo and O + A groups by immunohistochemical analysis. MAIN RESULTS AND THE ROLE OF CHANCE: RT-PCR showed that mRNA of hcpβ3 was expressed exclusively in testis. Western blot analysis detected hCPβ3 with anti-bovine CPβ3 antibody. Co-IP assay with recombinant protein showed that hCPα3 and hCPβ3 form a protein complex. At each step during spermatogenesis, the cellular localization of hCPβ3 changed dynamically. In spermatogonia, hCPβ3 showed a slight signal in cytoplasm. hCPβ3 expression was conspicuous mainly from spermatocytes, and hCPβ3 localization dynamically migrated from cytoplasm to the acrosomal cap and acrosome. In mature spermatozoa, hCPβ3 accumulated in the postacrosomal region and less so at the midpiece of the tail. Double-staining analysis revealed that hCPα3 localization was identical to hCPβ3 at every step in the spermatogenic cells. Most spermatozoa from the Normo group were stained homogenously by both hCPα3 and hCPβ3. In contrast, significantly more spermatozoa in the O + A versus Normo group showed heterogeneous or lack of staining for either hCPα3 or hCPβ3 (abnormal staining) (P < 0.001). The percentage of abnormal staining was higher in the O + A group (52.4 ± 3.0%) than in the Normo group (31.2 ± 2.5%). Even by confining the observations to morphologically normal spermatozoa selected in accordance with David's criteria, the percentage of abnormal staining was still higher in the O + A group (39.9 ± 2.9%) versus the Normo group (22.5 ± 2.1%) (P < 0.001). hCPβ3 in conjunction with hCPα3 seemed to play an important role in spermatogenesis and may be associated with male infertility. LARGE SCALE DATA: Not applicable. LIMITATIONS REASONS FOR CAUTION: Owing to the difficulty of collecting fresh samples of human testis, we used cryopreserved samples from testicular sperm extraction. To examine the interaction of spermatogenic cells or localization in seminiferous tubules, fresh testis sample of healthy males are ideal. WIDER IMPLICATIONS OF THE FINDINGS: The altered expression of hCPα3 and hCPβ3 may not only be a cause of male infertility but also a prognostic factor for the results of ART. They may be useful biomarkers to determine the fertilization ability of human sperm in ART. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (JP16K20133). The authors declare no competing interests.
引用
- Soda T, Miyagawa Y, Ueda N, et al. Systematic characterization of human testis-specific actin capping protein β3 as a possible biomarker for male infertility. Hum Reprod. 2017. PMID: 28104696. doi:10.1093/humrep/dew353
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。